Financials
Financial year 2024
PHARMA VISION from Sint-Agatha-Berchem, company number BE0875626918, closed financial year 2024 with a result of € 134,352 after tax. For that financial year PHARMA VISION recorded a gross margin of € 223,619 and equity of € 55,788. Compared with financial year 2023, the result moved from € 83,219 to € 134,352. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 16, 2025.
€ 55,788
▼ 40% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 134,352
▲ 61% vs 2023
Profit after tax over the fiscal year.
€ 46,532
▼ 74% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 172,022 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2024
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 4,961
▲ 34% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 66,742
▲ 8% vs 2023
Loans from banks and other lenders, long and short.
€ 3,062
▲ 6% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 73,123
▼ 33% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 301,592 | € 205,336 | € 132,117 | € 223,619 | ▲ 69% |
| Profit after taxes | € 206,433 | € 131,359 | € 83,219 | € 134,352 | ▲ 61% |
| Equity | € 94,925 | € 94,925 | € 93,458 | € 55,788 | ▼ 40% |
| Total debts | € 292,575 | € 303,629 | € 238,786 | € 285,275 | ▲ 19% |
| Cash | € 126,042 | € 129,334 | € 176,441 | € 46,532 | ▼ 74% |
| Retained profit | € 82,525 | € 82,525 | € 81,058 | € 43,388 | ▼ 46% |
| Dividend | € 206,433 | € 131,359 | € 84,686 | € 172,022 | ▲ 103% |
| Bank debt | € 22,844 | € 68,664 | € 61,959 | € 66,742 | ▲ 8% |
| Balance sheet total | € 387,500 | € 398,554 | € 332,244 | € 341,063 | ▲ 3% |
Key figures of PHARMA VISION, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to PHARMA VISION?
What happened at PHARMA VISION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 134,352 (▲ 61% vs 2023). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Sint-Jans-Molenbeek. KBO
- Frederic ROLLAND became a director. NBB
In short
From € 206,433 profit in 2021 to € 134,352 profit in 2024.
Paid € 213,298 in corporate taxes since 2021.
Best year ever: 2021, with € 206,433 profit.
Paid out € 594,501 in dividends to the owners in total.
A new publication or filing at PHARMA VISION? We notify you, reason included.
Follow PHARMA VISIONDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMA VISION is Frederic ROLLAND.
Directors
According to the 2024 annual accounts
Frederic ROLLAND
Director
since 2005
Establishments
Establishment units
Physical locations of this company
Weilandstraat 24 box 7
1082 Sint-Agatha-Berchem
Zaadstraat 73 box 13
1080 Sint-Jans-Molenbeek
Active since 16 August 2005
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →LOGIGOLD
€ -60,101 gross margin · 2025
KEYSER SOZE
€ -6,286 gross margin · 2025
BUGOOD FOOD
€ -1,391 gross margin · 2025
RBO CONSULTING
€ 75,220 revenue · 2022
Zicoteam-RCTA en abregé RCTA
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0875.626.918
- VAT number
- BE 0875.626.918
- Registered office
- Weilandstraat 24 bus 7, 1082 Sint-Agatha-Berchem
- Names & denominations
- PHARMA VISION
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 August 2005
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering